From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

Imagine a world where an HIV prevention method lasts for six months, offering protection without the daily hassle of taking a ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Failure to ensure that everyone has access to prevention options to protect oneself from HIV acquisition, has resulted in at ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...